Clinical Trial Update: Treatment of Graves´ophthalmopathy with Simvastatin (GO-S) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating simvastatin for Graves' ophthalmopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy
• Thyroid-associated Ophthalmopathy

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Lund University | Conditions: Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy | Phase 3 | Status: RECRUITING